Citation

Marcinko D, Vuksan-Cusa B. Psychiatr. Danub. 2009; 21(3): 386-390.

Copyright

(Copyright © 2009, Facultas Universitatis Studiorum Zagrabiensis - Danube Symposion of Psychiatry)

DOI

unavailable

PMID

19794362

Abstract

Suicidality is one of the great challenges in contemporary psychiatry. Suicidal patients are often misdiagnosed in clinical practice. It is very important to evaluate possible comorbidity in diagnostic assessment of suicidal patients. The high prevalence of comorbid bipolar (BD) and borderline personality disorders (BPD) presents both a diagnostic and a therapeutic challenge. Although the primary treatment for patients with BPD is psychotherapy, pharmacotherapy is a core component for the treatment of comorbid conditions such as bipolar disorder. Because of heterogeneity of the BPD, pharmacologic treatment has evolved to some particular dimensions of BPD rather than the disorder in its entirety. The dimensions include affective instability, impulsive aggression and identity disturbance. Effective medication management reduces the overall suffering of the patient and enables to make greater use of psychotherapeutic interventions which is very important for BPD patients with BD comorbidity.

Language: en

Keywords

Antimanic Agents; Bipolar Disorder; Borderline Personality Disorder; Combined Modality Therapy; Comorbidity; Diagnosis, Dual (Psychiatry); Humans; Psychotherapy; Risk; Suicide, Attempted